Pharmafile Logo

toothbrush

- PMLiVE

PMLiVE’s T40 – results announced!

The list highlights the creative agencies that had the most impact on the UK healthcare sector in 2023

- PMLiVE

Merck’s Keytruda shows promise as perioperative head and neck cancer treatment

More than 58,450 new cases of the disease are expected to be diagnosed in the US this year

- PMLiVE

Astellas and AviadoBio enter exclusive dementia gene therapy deal worth over $2bn

Frontotemporal dementia accounts for less than one in 30 cases of the neurodegenerative disorder

- PMLiVE

Merck and Mestag enter inflammatory disease partnership worth up to $1.9bn

The agreement will see Mestag use its platform designed to model the pathogenic role of fibroblasts

- PMLiVE

FREE Origins Webinar: How Patient Involvement is Transforming Clinical Trials – Reserve Your Spot Today!

Only one week to go until our highly anticipated webinar: “Why Patient Perspectives Matter: Driving Success in Clinical Trials”!   We’re thrilled to have Wendy Erler and Alfred Samuels joining...

Origins – The Patient Focused Specialists

- PMLiVE

Navigating US payer evidence needs to optimise market access

What clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How...

Petauri Evidence

- PMLiVE

AstraZeneca/Avillion share positive phase 3 results for asthma rescue treatment Airsupra

The chronic respiratory disease is estimated to affect up to 262 million people globally

- PMLiVE

J&J’s Erleada shows overall survival benefit in head-to-head prostate cancer study

Approximately 300,000 new cases of the disease are diagnosed in the US every year

- PMLiVE

ICR researchers reveal benefits of personalised radiotherapy for bladder cancer patients

More than 130,000 patients are treated with radiotherapy on the NHS every year

- PMLiVE

Medscape Education Breathes Life Into Pulmonology: Showcasing Success at CHEST 2024

Medscape Education showcases its strong track record in providing high-quality education in the field of pulmonology at the annual conference of the American College of Chest Physicians in Boston, Massachusetts,...

Medscape Education

- PMLiVE

AbbVie shares promising late-stage results for Parkinson’s disease candidate tavapadon

Approximately 153,000 people in the UK are currently living with the neurodegenerative disorder

- PMLiVE

ABPI highlights importance of NHS-industry partnerships in improving patient outcomes

Hospitals engaging in industry partnerships were found to be up to 2.5 times more likely to follow NICE guidelines

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links